Life Sciences Entrepreneur Seminar Series

"Life science venture creation – Lessons learned…often the hard way"

Kevin Pojasek

Venture partner at SV Health investors

Kevin is a Venture Partner at SV Health Investors, a 25 year old venture capital firm with ~$3b under management, where he focuses on creating and leading early stage life science companies. Kevin is also the CEO of Ervaxx, an Oxford-based SV portfolio company pursuing novel cancer antigens as targets for off-the-shelf cancer vaccines and other immunotherapies. His career has focused on building biotech companies based largely on academic insights with the goal of developing improved therapies for patients.

This event is supported by the NIHR Oxford Biomedical Research Centre

Date: Tuesday 26^th March
Time: 5.30pm - 7pm
Venue: Old Library, University Church (enter through the Vaults & Garden, Radcliffe Square)
Followed by networking buffet catered by the Vaults & Garden

ALL WELCOME

For queries contact Cassandra.Adams@sgc.ox.ac.uk